Directors Deals 

AstraZeneca chief in for a million

AstraZeneca chief in for a million

A month after AstraZeneca (AZN) announced a $3.5bn (£2.7bn) placing to help fund its partnership with Japanese pharma group Daiichi Sankyo, several directors have bumped up their holdings, chief among them chief executive Pascal Soriot, who forked out nearly £1m to drive up his stake by around 60 per cent.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now